Aurobindo Pharma (AUROPHARMA) Share Price rises 2.19% as stock trades at Rs 1,678

Aurobindo Pharma Share Price is trading higher today at Rs 1,678, up 2.19% from the previous close of Rs 1,642. The company’s market capitalisation stands at Rs 96,951.18 Cr, placing Aurobindo Pharma Share Price in focus for investors tracking Aurobindo Pharma Share Price Today, Aurobindo Pharma Stock News and broader Healthcare names on Univest. The price move is confirmed in Univest data; a company-specific reason has not been established. The move keeps Aurobindo Pharma Share Price relevant for readers looking at stock analysis, valuation context and sector positioning rather than a single-day headline alone.

Aurobindo Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,678
Previous Close	Rs 1,642
Today's Move	Rs 36 (+2.19%)
Open	Rs 1,642.05
High	Rs 1,678
Low	Rs 1,633.35
Market Capitalisation	Rs 96,951.18 crore
Market Cap Category	Large Cap

Aurobindo Pharma Ltd. (AUROPHARMA) rose to Rs 1,678 from the previous close of Rs 1,642, a move of Rs 36 or 2.19%. The stock opened at Rs 1,642.05, reached a high of Rs 1,678, recorded a low of Rs 1,633.35.

Aurobindo Pharma Share Price is up Rs 36 today, and the stock is trading at Rs 1,678 after opening at Rs 1,642.05. The day’s low stands at Rs 1,633.35, while the high is Rs 1,678, which is also the latest traded price. The share price rise places Aurobindo Pharma Share Price among the stocks rising today, with a 2.19% gain from the previous close.

According to latest Univest data, the first-hour to mid-session setup shows a move that stayed within a relatively tight intraday band. For readers following Aurobindo Pharma Share Price Live and Aurobindo Pharma Share Price Update, the important facts are the current price, previous close, open and the day’s high-low range. Aurobindo Pharma Share Price today is therefore best read as a confirmed price rise, not as a signal of any stated catalyst. The next layer of analysis comes from Aurobindo Pharma Fundamental Analysis and the company’s valuation profile.

Aurobindo Pharma Ltd. (AUROPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 96,951.18 crore
P/E Ratio	25.45x
P/B Ratio	2.43x
ROE	9.93%
ROCE	12.76%
EPS	Rs 64.52
Book Value Per Share	Rs 676.49
Dividend Yield	0.24%

Aurobindo Pharma Ltd. (AUROPHARMA) fundamental metrics show P/E 25.45x, P/B 2.43x, ROE 9.93%, ROCE 12.76%. These ratios show where the company stands today and are not a call to buy or sell.

Aurobindo Pharma Ltd. has a market capitalisation of Rs 96,951.18 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.45x, P/B at 2.43x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.93% and ROCE of 12.76%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 64.52, book value per share of Rs 676.49, dividend yield of 0.24%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.28x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	25.45x
Benchmark Median P/E	31.28x
Benchmark Average P/E	47.09x
Benchmark P/E Range	3.56x to 678.22x
Company P/B Ratio	2.43x
Benchmark Median P/B	2.85x
Company ROE	9.93%
Benchmark Median ROE	11.61%
Company ROCE	12.76%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 96,951.18 crore
Benchmark Median Market Cap	Rs 821.44 crore

Aurobindo Pharma Ltd. (AUROPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 25.45x, which is below the benchmark median of 31.28x, a difference of -18.64%. A P/E difference of this kind is a reference point rather than a recommendation.

Aurobindo Pharma Ltd. (AUROPHARMA) has a ROE of 9.93%, which is below the benchmark median of 11.61%, a difference of -14.47%. Aurobindo Pharma Ltd. (AUROPHARMA) has a ROCE of 12.76%, which is below the benchmark median of 13.46%, a difference of -5.2%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,27,861.41	34.76	4.86	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,54,318.9	85.21	14.11	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,79,153.26	81.53	19.81	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,111.94	24.65	4.13	19.69	21.39
Laurus Labs Ltd.	LAURUSLABS	1,11,034.16	98.83	19.16	18.31	18.2

Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 25.45x compared with the displayed peer median of 81.53x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.93% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 12.76% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Aurobindo Pharma Ltd. (AUROPHARMA) has a market capitalisation of Rs 96,951.18 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Aurobindo Pharma

• Aurobindo Pharma Share Price is trading at Rs 1,678, with a 2.19% gain and a Rs 96,951.18 Cr market capitalisation.
• The latest Univest figures show Aurobindo Pharma Share Price above the previous close of Rs 1,642, with the day’s high at Rs 1,678.
• Aurobindo Pharma Fundamental Analysis shows a P/E of 25.45, P/B of 2.43, ROE of 9.93% and ROCE of 12.76%.
• Sector Analysis places Aurobindo Pharma Share Price below the industry median P/E and P/B within Healthcare.
• Peer Comparison shows valuation below several pharma peers, which keeps Aurobindo Pharma Share Price in focus on Univest.

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Aurobindo Pharma Share Price reflects a business that investors follow for its pharma manufacturing and product exposure within a large listed healthcare universe. The company is tracked on NSE and BSE, and its market capitalisation of Rs 96,951.18 Cr places it among the notable names in the sector.

For readers studying Aurobindo Pharma Stock News, the main business context is straightforward: the company sits in a regulated industry where earnings quality, capital returns and valuation all matter. Aurobindo Pharma Share Price Today can be interpreted through its reported ratios, earnings per share, book value and dividend yield rather than through a single-day move alone. Univest keeps this business context alongside the price action so that Aurobindo Pharma Share Price remains connected to fundamentals, company overview and sector analysis.

Frequently Asked Questions

Why is Aurobindo Pharma Share Price rising today?

Ans. Aurobindo Pharma Share Price is up 2.19% today to Rs 1,678. According to Univest data, the price event is confirmed, but no company-specific catalyst is established, so the move should be read as price action first.

What is Aurobindo Pharma Share Price today?

Ans. Aurobindo Pharma Share Price today is Rs 1,678, compared with the previous close of Rs 1,642. The stock is trading higher by Rs 36, and the day’s high also stands at Rs 1,678.

What is Aurobindo Pharma’s market capitalisation?

Ans. Aurobindo Pharma Share Price is backed by a market capitalisation of Rs 96,951.18 Cr. That size places the company well above the industry median and gives important context to Aurobindo Pharma Share Price Today.

What does Aurobindo Pharma Fundamental Analysis show?

Ans. Aurobindo Pharma Fundamental Analysis shows a P/E of 25.45, P/B of 2.43, ROE of 9.93%, ROCE of 12.76%, EPS of Rs 64.52 and book value of Rs 676.49. These numbers frame Aurobindo Pharma Share Price.

How does Aurobindo Pharma compare with sector benchmarks?

Ans. In the same industry benchmark, Aurobindo Pharma Share Price has a P/E below the median of 31.28 and a P/B below the median of 2.85. ROE and ROCE are also below the benchmark medians.

How does Aurobindo Pharma compare with pharma peers?

Ans. Aurobindo Pharma Share Price has a lower P/B than Sun Pharma, Divi's Labs, Torrent Pharma, Zydus Lifesciences and Laurus Labs. Its P/E is below most of these peers, while return ratios are also lower.

What is Aurobindo Pharma’s EPS and book value?

Ans. Aurobindo Pharma Share Price is supported by EPS of Rs 64.52 and book value of Rs 676.49. EPS shows earnings attributable to each share, while book value shows accounting net worth per share.

What is the dividend yield on Aurobindo Pharma Share Price?

Ans. Aurobindo Pharma Share Price carries a dividend yield of 0.24%. This is a historical payout measure and should be read with earnings, valuation and capital efficiency rather than in isolation.

Track Aurobindo Pharma Share Price on Univest

Use Aurobindo Pharma Ltd. (AUROPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Aurobindo Pharma Share Price on Univest for live price updates, valuation ratios, 52-week levels and market insights. If you follow Aurobindo Pharma Share Price Today, Univest brings the latest Univest figures together with context on financial ratios, sector comparison and peer positioning. That makes Aurobindo Pharma Share Price easier to monitor across daily moves and longer-term fundamental checks.